ReP USP - Resultado da busca

Artigo de periodico
Adverse events of vaccines and the consequences of non-vaccination: a critical review (2018)
Aps, Luana Raposo de Melo Moraes; Piantola, Marco Aurélio Floriano; Pereira, Sara Araújo; Castro, Julia Tavares; Santos, Fernanda Ayane de Oliveira; Ferreira, Luís Carlos de Souza
Source: Revista de Saude Publica. Unidade: ICB
Subjects: MICROBIOLOGIA, VACINAS, VACINAÇÃO, IMUNIZAÇÃO, DOENÇAS TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APS, Luana Raposo de Melo Moraes et al. Adverse events of vaccines and the consequences of non-vaccination: a critical review. Revista de Saude Publica, v. 52, n. 40, p. 1-13, 2018Tradução . . Disponível em: http://www.revistas.usp.br/rsp/article/view/145028á. Acesso em: 09 nov. 2024.
APA
Aps, L. R. de M. M., Piantola, M. A. F., Pereira, S. A., Castro, J. T., Santos, F. A. de O., & Ferreira, L. C. de S. (2018). Adverse events of vaccines and the consequences of non-vaccination: a critical review. Revista de Saude Publica, 52( 40), 1-13. doi:10.11606/s1518-8787.2018052000384
NLM
Aps LR de MM, Piantola MAF, Pereira SA, Castro JT, Santos FA de O, Ferreira LC de S. Adverse events of vaccines and the consequences of non-vaccination: a critical review [Internet]. Revista de Saude Publica. 2018 ; 52( 40): 1-13.[citado 2024 nov. 09 ] Available from: http://www.revistas.usp.br/rsp/article/view/145028á
Vancouver
Aps LR de MM, Piantola MAF, Pereira SA, Castro JT, Santos FA de O, Ferreira LC de S. Adverse events of vaccines and the consequences of non-vaccination: a critical review [Internet]. Revista de Saude Publica. 2018 ; 52( 40): 1-13.[citado 2024 nov. 09 ] Available from: http://www.revistas.usp.br/rsp/article/view/145028á
Artigo de periodico
Recombinant vaccines of a CD4+ T-cell epitope promote eficiente control of Paracoccidioides brasiliensis burden by restraining primary organ infection (2017)
Holanda, Rodrigo Assunção; Muñoz, Julián Esteban; Dias, Lucas Santos; Silva, Leandro Buffoni Roque; Santos, Julliana Ribeiro Alves; Pagliari, Sthefany; Vieira, Érica Leandro Marciano; Paixão, Tatiane Alves; Taborda, Carlos Pelleschi ; Santos, Daniel de Assis; Bruña-Romero, Oscar
Source: PLoS Neglected Tropical Diseases. Unidade: ICB
Subjects: MICROBIOLOGIA, PARACOCCIDIOIDES BRASILIENSIS, PROTEÍNAS RECOMBINANTES, VACINAS, LINFÓCITOS T, IMUNOGENICIDADE DA VACINA, ANTÍGENOS DE FUNGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOLANDA, Rodrigo Assunção et al. Recombinant vaccines of a CD4+ T-cell epitope promote eficiente control of Paracoccidioides brasiliensis burden by restraining primary organ infection. PLoS Neglected Tropical Diseases, v. 11, n. 9, p. 1-20, 2017Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0005927. Acesso em: 09 nov. 2024.
APA
Holanda, R. A., Muñoz, J. E., Dias, L. S., Silva, L. B. R., Santos, J. R. A., Pagliari, S., et al. (2017). Recombinant vaccines of a CD4+ T-cell epitope promote eficiente control of Paracoccidioides brasiliensis burden by restraining primary organ infection. PLoS Neglected Tropical Diseases, 11( 9), 1-20. doi:10.1371/journal.pntd.0005927
NLM
Holanda RA, Muñoz JE, Dias LS, Silva LBR, Santos JRA, Pagliari S, Vieira ÉLM, Paixão TA, Taborda CP, Santos D de A, Bruña-Romero O. Recombinant vaccines of a CD4+ T-cell epitope promote eficiente control of Paracoccidioides brasiliensis burden by restraining primary organ infection [Internet]. PLoS Neglected Tropical Diseases. 2017 ; 11( 9): 1-20.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1371/journal.pntd.0005927
Vancouver
Holanda RA, Muñoz JE, Dias LS, Silva LBR, Santos JRA, Pagliari S, Vieira ÉLM, Paixão TA, Taborda CP, Santos D de A, Bruña-Romero O. Recombinant vaccines of a CD4+ T-cell epitope promote eficiente control of Paracoccidioides brasiliensis burden by restraining primary organ infection [Internet]. PLoS Neglected Tropical Diseases. 2017 ; 11( 9): 1-20.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1371/journal.pntd.0005927
Artigo de periodico
Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis (2017)
Nascimento, Ivan Pereira; Rodriguez, Dúnia; Santos, Carina Carvalho dos; Amaral, Eduardo Pinheiro; Rofatto, Henrique Krambeck; Junqueira-Kipnis, Ana Paula; Gonçalves, Eduardo Dantas Casillo; Lima, Maria Regina D'Império ; Hirata, Mario Hiroyuki ; Silva, Célio Lopes; Winter, Nathalie; Gicquel, Brigitte; Mills, Kingston H G; Pizza, Mariagrazia; Rappuoli, Rino; Leite, Luciana C. C
Source: Scientific Reports. Unidades: ICB, FCF, FMRP
Subjects: IMUNOLOGIA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, VACINAS, CITOCININAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Ivan Pereira et al. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, v. 7, n. 1, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-02003-9. Acesso em: 09 nov. 2024.
APA
Nascimento, I. P., Rodriguez, D., Santos, C. C. dos, Amaral, E. P., Rofatto, H. K., Junqueira-Kipnis, A. P., et al. (2017). Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, 7( 1), 1-11. doi:10.1038/s41598-017-02003-9
NLM
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Vancouver
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Artigo de periodico
Induction of resident memory T cells enhances the efficacy of cancer (2017)
Nizard, Mevyn; Roussel, Hélène; Diniz, Mariana de Oliveira; Karaki, Soumaya; Tran, Thi; Voron, Thibault; Dransart, Estelle; Sandoval, Federico; Riquet, Marc; Rance, Bastien; Marcheteau, Elie; Fabre, Elizabeth; Mandavit, Marion; Terme, Magali; Blanc, Charlotte; Escudie, Jean-Baptiste; Gibault, Laure; Barthes, Françoise Le Pimpec; Granier, Clemence; Ferreira, Luís Carlos de Souza ; Badoual, Cecile; Johannes, Ludger; Tartour, Eric
Source: Nature Communications. Unidade: ICB
Subjects: MICROBIOLOGIA, LINFÓCITOS T, VACINAS, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NIZARD, Mevyn et al. Induction of resident memory T cells enhances the efficacy of cancer. Nature Communications, v. 8, n. 15221, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/ncomms15221. Acesso em: 09 nov. 2024.
APA
Nizard, M., Roussel, H., Diniz, M. de O., Karaki, S., Tran, T., Voron, T., et al. (2017). Induction of resident memory T cells enhances the efficacy of cancer. Nature Communications, 8( 15221), 1-11. doi:10.1038/ncomms15221
NLM
Nizard M, Roussel H, Diniz M de O, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie J-B, Gibault L, Barthes FLP, Granier C, Ferreira LC de S, Badoual C, Johannes L, Tartour E. Induction of resident memory T cells enhances the efficacy of cancer [Internet]. Nature Communications. 2017 ; 8( 15221): 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/ncomms15221
Vancouver
Nizard M, Roussel H, Diniz M de O, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie J-B, Gibault L, Barthes FLP, Granier C, Ferreira LC de S, Badoual C, Johannes L, Tartour E. Induction of resident memory T cells enhances the efficacy of cancer [Internet]. Nature Communications. 2017 ; 8( 15221): 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/ncomms15221
Artigo de periodico
Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi (2017)
Parente-Rocha, Juliana Alves; Bailão, Alexandre Melo; Amaral, André Correa; Taborda, Carlos Pelleschi ; Paccez, Juliano Domiraci; Borges, Clayton Luiz; Pereira, Maristela
Source: Mediators of Inflammation. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIFÚNGICOS, FUNGOS, METABOLISMO VEGETAL, VACINAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, MICOLOGIA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE-ROCHA, Juliana Alves et al. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators of Inflammation, v. 2017, p. 1-16, 2017Tradução . . Disponível em: https://doi.org/10.1155/2017/9870679. Acesso em: 09 nov. 2024.
APA
Parente-Rocha, J. A., Bailão, A. M., Amaral, A. C., Taborda, C. P., Paccez, J. D., Borges, C. L., & Pereira, M. (2017). Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators of Inflammation, 2017, 1-16. doi:10.1155/2017/9870679
NLM
Parente-Rocha JA, Bailão AM, Amaral AC, Taborda CP, Paccez JD, Borges CL, Pereira M. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi [Internet]. Mediators of Inflammation. 2017 ; 2017 1-16.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1155/2017/9870679
Vancouver
Parente-Rocha JA, Bailão AM, Amaral AC, Taborda CP, Paccez JD, Borges CL, Pereira M. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi [Internet]. Mediators of Inflammation. 2017 ; 2017 1-16.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1155/2017/9870679
Artigo de periodico
LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 (2017)
Batista, Milene Tavares; Ferreira, Ewerton Lucena; Pereira, Gisela de Souza; Stafford, Phillip; Maeda, Denicar Lina Nascimento Fabris; Rodrigues, Juliana Falcão; Brady, L. Jeannine; Johnston, Stephen Albert; Ferreira, Luís Carlos de Souza ; Ferreira, Rita de Cássia Café
Source: Vaccine. Unidade: ICB
Subjects: STREPTOCOCCUS MUTANS, ANTICORPOS MONOCLONAIS, ADJUVANTES IMUNOLÓGICOS, PEPTÍDEOS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, EPITOPOS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Milene Tavares et al. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, v. 35, n. 52, p. 7273-7282, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.11.007. Acesso em: 09 nov. 2024.
APA
Batista, M. T., Ferreira, E. L., Pereira, G. de S., Stafford, P., Maeda, D. L. N. F., Rodrigues, J. F., et al. (2017). LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, 35( 52), 7273-7282. doi:10.1016/j.vaccine.2017.11.007
NLM
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007
Vancouver
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007
Artigo de periodico
A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice (2016)
Tran, Thi; Dransart, Estelle; Gey, Alain; Merillon, Nathalie; Lone, Yu Chun; Godefroy, Sylvie; Sibley, Craig; Ferreira, Luís Carlos de Souza ; Medioni, Jacques; Oudard, Stephane; Johannes, Ludger; Tartour, Eric
Source: Clinical Cancer Research. Unidade: ICB
Subjects: MICROBIOLOGIA, CÉLULAS DENDRÍTICAS, ORGANISMOS GENETICAMENTE MODIFICADOS, CAMUNDONGOS, VACINAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRAN, Thi et al. A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice. Clinical Cancer Research, v. 16, n. 22, p. 4133-4144, 2016Tradução . . Disponível em: https://doi.org/10.1158/1078-0432.CCR-16-0044. Acesso em: 09 nov. 2024.
APA
Tran, T., Dransart, E., Gey, A., Merillon, N., Lone, Y. C., Godefroy, S., et al. (2016). A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice. Clinical Cancer Research, 16( 22), 4133-4144. doi:10.1158/1078-0432.CCR-16-0044
NLM
Tran T, Dransart E, Gey A, Merillon N, Lone YC, Godefroy S, Sibley C, Ferreira LC de S, Medioni J, Oudard S, Johannes L, Tartour E. A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice [Internet]. Clinical Cancer Research. 2016 ; 16( 22): 4133-4144.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1158/1078-0432.CCR-16-0044
Vancouver
Tran T, Dransart E, Gey A, Merillon N, Lone YC, Godefroy S, Sibley C, Ferreira LC de S, Medioni J, Oudard S, Johannes L, Tartour E. A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice [Internet]. Clinical Cancer Research. 2016 ; 16( 22): 4133-4144.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1158/1078-0432.CCR-16-0044
Artigo de periodico
Modulating APOBEC expression enhances DNA vaccine immunogenicity (2015)
Almeida, Rafael Ribeiro; Raposo, Rui André Saraiva; Coirada, Fernanda Caroline; Silva, Jamile Ramos da; Ferreira, Luís Carlos de Souza ; Kalil, Jorge; Nixon, Douglas F.; Cunha-Neto, Edecio
Source: Immunology and Cell Biology. Unidades: ICB, FM
Subjects: IMUNOGENÉTICA, DNA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Rafael Ribeiro et al. Modulating APOBEC expression enhances DNA vaccine immunogenicity. Immunology and Cell Biology, v. 93, n. 10, p. 868-876, 2015Tradução . . Disponível em: https://doi.org/10.1038/icb.2015.53. Acesso em: 09 nov. 2024.
APA
Almeida, R. R., Raposo, R. A. S., Coirada, F. C., Silva, J. R. da, Ferreira, L. C. de S., Kalil, J., et al. (2015). Modulating APOBEC expression enhances DNA vaccine immunogenicity. Immunology and Cell Biology, 93( 10), 868-876. doi:10.1038/icb.2015.53
NLM
Almeida RR, Raposo RAS, Coirada FC, Silva JR da, Ferreira LC de S, Kalil J, Nixon DF, Cunha-Neto E. Modulating APOBEC expression enhances DNA vaccine immunogenicity [Internet]. Immunology and Cell Biology. 2015 ; 93( 10): 868-876.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/icb.2015.53
Vancouver
Almeida RR, Raposo RAS, Coirada FC, Silva JR da, Ferreira LC de S, Kalil J, Nixon DF, Cunha-Neto E. Modulating APOBEC expression enhances DNA vaccine immunogenicity [Internet]. Immunology and Cell Biology. 2015 ; 93( 10): 868-876.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/icb.2015.53
Artigo de periodico
Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses (2015)
Santana, Vinicius Canato; Almeida, Rafael Ribeiro; Ribeiro, Susan Pereira; Ferreira, Luís Carlos de Souza ; Kalil, Jorge; Rosa, Caniela Santoro; Cunha-Neto, Edecio
Source: Memórias do Instituto Oswaldo Cruz. Unidade: ICB
Subjects: MICROBIOLOGIA, MACRÓFAGOS, GRANULÓCITOS, VACINAS, DNA VIRAL, PLASMIDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Vinicius Canato et al. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses. Memórias do Instituto Oswaldo Cruz, v. 110, n. 8, p. 1010-1016, 2015Tradução . . Disponível em: https://doi.org/10.1590/0074-02760150283. Acesso em: 09 nov. 2024.
APA
Santana, V. C., Almeida, R. R., Ribeiro, S. P., Ferreira, L. C. de S., Kalil, J., Rosa, C. S., & Cunha-Neto, E. (2015). Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses. Memórias do Instituto Oswaldo Cruz, 110( 8), 1010-1016. doi:10.1590/0074-02760150283
NLM
Santana VC, Almeida RR, Ribeiro SP, Ferreira LC de S, Kalil J, Rosa CS, Cunha-Neto E. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses [Internet]. Memórias do Instituto Oswaldo Cruz. 2015 ; 110( 8): 1010-1016.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1590/0074-02760150283
Vancouver
Santana VC, Almeida RR, Ribeiro SP, Ferreira LC de S, Kalil J, Rosa CS, Cunha-Neto E. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses [Internet]. Memórias do Instituto Oswaldo Cruz. 2015 ; 110( 8): 1010-1016.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1590/0074-02760150283
Artigo de periodico
Bacillus subtilis spores as adjuvants for DNA vaccines (2015)
Aps, Luana Raposo de Melo Moraes; Diniz, Mariana Oliveira; Porchia, Bruna F. M. M.; Sales, Natiely Sila; Moreno, Ana Carolina Ramos; Ferreira, Luís Carlos de Souza
Source: Vaccine. Unidade: ICB
Subjects: MICROBIOLOGIA, VACINAS, DNA, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APS, Luana Raposo de Melo Moraes et al. Bacillus subtilis spores as adjuvants for DNA vaccines. Vaccine, v. 33, n. 20, p. 2328-2334, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2015.03.043. Acesso em: 09 nov. 2024.
APA
Aps, L. R. de M. M., Diniz, M. O., Porchia, B. F. M. M., Sales, N. S., Moreno, A. C. R., & Ferreira, L. C. de S. (2015). Bacillus subtilis spores as adjuvants for DNA vaccines. Vaccine, 33( 20), 2328-2334. doi:10.1016/j.vaccine.2015.03.043
NLM
Aps LR de MM, Diniz MO, Porchia BFMM, Sales NS, Moreno ACR, Ferreira LC de S. Bacillus subtilis spores as adjuvants for DNA vaccines [Internet]. Vaccine. 2015 ; 33( 20): 2328-2334.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.vaccine.2015.03.043
Vancouver
Aps LR de MM, Diniz MO, Porchia BFMM, Sales NS, Moreno ACR, Ferreira LC de S. Bacillus subtilis spores as adjuvants for DNA vaccines [Internet]. Vaccine. 2015 ; 33( 20): 2328-2334.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.vaccine.2015.03.043
Artigo de periodico
Adsorption of toll-like receptor 4 agonist to alum-based tetanus toxoid vaccine dampens pro-T helper 2 activities and enhances antibody responses (2015)
Bortolatto, Juliana; Mirotti, Luciana; Rodriguez, Dunia; Gomes, Eliane; Russo, Momtchilo
Source: Journal of Immunology Research. Unidade: ICB
Subjects: IMUNOLOGIA, ADJUVANTES IMUNOLÓGICOS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLATTO, Juliana et al. Adsorption of toll-like receptor 4 agonist to alum-based tetanus toxoid vaccine dampens pro-T helper 2 activities and enhances antibody responses. Journal of Immunology Research, v. 2015, p. 1-9, 2015Tradução . . Disponível em: https://doi.org/10.1155/2015/280238. Acesso em: 09 nov. 2024.
APA
Bortolatto, J., Mirotti, L., Rodriguez, D., Gomes, E., & Russo, M. (2015). Adsorption of toll-like receptor 4 agonist to alum-based tetanus toxoid vaccine dampens pro-T helper 2 activities and enhances antibody responses. Journal of Immunology Research, 2015, 1-9. doi:10.1155/2015/280238
NLM
Bortolatto J, Mirotti L, Rodriguez D, Gomes E, Russo M. Adsorption of toll-like receptor 4 agonist to alum-based tetanus toxoid vaccine dampens pro-T helper 2 activities and enhances antibody responses [Internet]. Journal of Immunology Research. 2015 ; 2015 1-9.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1155/2015/280238
Vancouver
Bortolatto J, Mirotti L, Rodriguez D, Gomes E, Russo M. Adsorption of toll-like receptor 4 agonist to alum-based tetanus toxoid vaccine dampens pro-T helper 2 activities and enhances antibody responses [Internet]. Journal of Immunology Research. 2015 ; 2015 1-9.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1155/2015/280238
Artigo de periodico
Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites (2014)
Nizard, Mevyn; Diniz, Mariana Oliveira; Roussel, Helene; Tran, Thi; Ferreira, Luís Carlos de Souza ; Badoual, Cecile; Tartour, Eric
Source: Human Vaccines & Immunotherapeutics. Unidade: ICB
Subjects: MICROBIOLOGIA, VACINAS, PATÓGENOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NIZARD, Mevyn et al. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Human Vaccines & Immunotherapeutics, v. 10, n. 8, p. 2175-2187, 2014Tradução . . Disponível em: https://doi.org/10.4161/hv.29269. Acesso em: 09 nov. 2024.
APA
Nizard, M., Diniz, M. O., Roussel, H., Tran, T., Ferreira, L. C. de S., Badoual, C., & Tartour, E. (2014). Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Human Vaccines & Immunotherapeutics, 10( 8), 2175-2187. doi:10.4161/hv.29269
NLM
Nizard M, Diniz MO, Roussel H, Tran T, Ferreira LC de S, Badoual C, Tartour E. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites [Internet]. Human Vaccines & Immunotherapeutics. 2014 ; 10( 8): 2175-2187.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4161/hv.29269
Vancouver
Nizard M, Diniz MO, Roussel H, Tran T, Ferreira LC de S, Badoual C, Tartour E. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites [Internet]. Human Vaccines & Immunotherapeutics. 2014 ; 10( 8): 2175-2187.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4161/hv.29269
Artigo de periodico
Neisseria lactamica antigens complexed with a novel cationic adjuvant (2013)
Gaspar, Emanuelle B.; Rosetti, Andreza S.; Lincopan, Nilton ; Gaspari, Elizabeth De
Source: Human Vaccines & Immunotherapeutics. Unidade: ICB
Subjects: MICROBIOLOGIA, BACTÉRIAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, ADJUVANTES IMUNOLÓGICOS, VACINAS, ANTÍGENOS DE BACTÉRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAR, Emanuelle B. et al. Neisseria lactamica antigens complexed with a novel cationic adjuvant. Human Vaccines & Immunotherapeutics, v. 9 n. 3, p. 572-581, 2013Tradução . . Disponível em: https://doi.org/10.4161/hv.23237. Acesso em: 09 nov. 2024.
APA
Gaspar, E. B., Rosetti, A. S., Lincopan, N., & Gaspari, E. D. (2013). Neisseria lactamica antigens complexed with a novel cationic adjuvant. Human Vaccines & Immunotherapeutics, 9 n. 3, 572-581. doi:10.4161/hv.23237
NLM
Gaspar EB, Rosetti AS, Lincopan N, Gaspari ED. Neisseria lactamica antigens complexed with a novel cationic adjuvant [Internet]. Human Vaccines & Immunotherapeutics. 2013 ; 9 n. 3 572-581.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4161/hv.23237
Vancouver
Gaspar EB, Rosetti AS, Lincopan N, Gaspari ED. Neisseria lactamica antigens complexed with a novel cationic adjuvant [Internet]. Human Vaccines & Immunotherapeutics. 2013 ; 9 n. 3 572-581.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4161/hv.23237

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration